Director Chris McKee granted 10,000 Crexendo (NASDAQ: CXDO) stock options at $6.47

Rhea-AI Filing Summary

Crexendo, Inc. director Chris McKee reported receiving a grant of stock options on March 4, 2026. The award covers 10,000 stock options with an exercise price of $6.47 per share, all held as direct ownership. The options vest over 36 equal monthly installments beginning on April 4, 2026, meaning the right to exercise builds gradually over three years rather than all at once.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McKee Chris

(Last) (First) (Middle)

1225 W WASHINGTON ST

STE 213

(Street)

TEMPE AZ 85288

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Crexendo, Inc. [ CXDO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options	$6.47	03/04/2026		A		10,000		(1)	03/04/2036	Common Stock	10,000	$6.47	10,000	D

Explanation of Responses:

1. The stock options vest over 36 equal monthly installments beginning on 4/4/2026.

	/s/ Chris McKee	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Crexendo (CXDO) director Chris McKee report?

Director Chris McKee reported receiving a grant of 10,000 Crexendo stock options. The derivative award was granted on March 4, 2026, at an exercise price of $6.47 per share, and is held as direct ownership.

What are the key terms of Chris McKee’s Crexendo (CXDO) option grant?

The grant consists of 10,000 stock options with a $6.47 exercise price. These options vest over 36 equal monthly installments beginning on April 4, 2026, gradually increasing the portion McKee is able to exercise over time.

Is Chris McKee’s Crexendo (CXDO) option grant a buy or sell transaction?

The reported transaction is an acquisition of derivative securities through a grant or award, not an open-market buy or sell. It increases McKee’s potential ownership via stock options rather than changing existing share holdings.

How many Crexendo (CXDO) options does Chris McKee hold after this transaction?

Following the March 4, 2026 grant, Chris McKee holds 10,000 stock options in Crexendo. These options are reported as directly owned and are subject to the 36-month vesting schedule beginning April 4, 2026.

How do the Crexendo (CXDO) options granted to Chris McKee vest over time?

The options vest in 36 equal monthly installments starting April 4, 2026. Each month, a portion of the 10,000 options becomes exercisable, aligning McKee’s potential equity ownership with longer-term service to the company.